These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 16191282

  • 21. Adult height in advanced puberty with or without gonadotropin hormone releasing hormone analog treatment.
    Couto-Silva AC, Adan L, Trivin C, Brauner R.
    J Pediatr Endocrinol Metab; 2002 Mar; 15(3):297-305. PubMed ID: 11924932
    [Abstract] [Full Text] [Related]

  • 22. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D, Karavani G, Hirsch HJ, Strich D.
    J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
    [Abstract] [Full Text] [Related]

  • 23. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, Cutler GB.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
    [Abstract] [Full Text] [Related]

  • 24. Can the TW3 bone age determination method provide additional criteria for growth hormone treatment in adopted girls with early puberty? A comparison of the Tanner-Whitehouse 3 method with the Greulich-Pyle and the Tanner-Whitehouse 2 methods.
    Proos LA, Lönnerholm T, Jonsson B, Tuvemo T.
    Horm Res Paediatr; 2010 Feb; 73(1):35-40. PubMed ID: 20190538
    [Abstract] [Full Text] [Related]

  • 25. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 26. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
    N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
    [Abstract] [Full Text] [Related]

  • 27. Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty.
    Kletter GB, Kelch RP.
    J Clin Endocrinol Metab; 1994 Aug 24; 79(2):331-4. PubMed ID: 8045943
    [No Abstract] [Full Text] [Related]

  • 28. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C, Regazzi C, Ndaka J, Vitale R, Bernasconi S.
    Acta Biomed; 2005 Sep 24; 76(2):73-8. PubMed ID: 16350551
    [Abstract] [Full Text] [Related]

  • 29. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec 24; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 30. Use of a Gonadotropin-releasing Hormone Analog to Treat Idiopathic Central Precocious Puberty Is Not Associated with Changes in Bone Structure in Postmenarchal Adolescents.
    Iannetta R, Melo AS, Iannetta O, Marchini JS, Paula FJ, Martinelli CE, Rosa e Silva AC, Ferriani RA, Martins WP, Reis RM.
    J Pediatr Adolesc Gynecol; 2015 Oct 24; 28(5):304-8. PubMed ID: 26081481
    [Abstract] [Full Text] [Related]

  • 31. Growth and pubertal development during and after treatment with a slow-release gonadotropin-releasing hormone agonist in central precocious puberty.
    Oostdijk W, Gevers EF, Drop SL, Rikken B, Hümmelink R, Partsch CJ, Sippell WG.
    Horm Res; 1991 Oct 24; 36(3-4):121-5. PubMed ID: 1840141
    [Abstract] [Full Text] [Related]

  • 32. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential.
    Toumba M, Kokotsis V, Savva SC, Skordis N.
    J Pediatr Endocrinol Metab; 2014 Mar 24; 27(3-4):311-6. PubMed ID: 24158419
    [Abstract] [Full Text] [Related]

  • 33. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.
    Weise M, Flor A, Barnes KM, Cutler GB, Baron J.
    J Clin Endocrinol Metab; 2004 Jan 24; 89(1):103-7. PubMed ID: 14715835
    [Abstract] [Full Text] [Related]

  • 34. [Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty].
    Wang CL, Liang L, Liu PN, Jin XJ, Chen LQ, Yang F, Lian Q, Chen RM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan 24; 16(1):25-30. PubMed ID: 24461173
    [Abstract] [Full Text] [Related]

  • 35. [Recommendations for the diagnosis and treatment of central precocious puberty].
    Group of Endocrine and Genetic Metabolic Diseases, Chinese Society Of Pediatrics, Chinese Medical Association.
    Zhonghua Er Ke Za Zhi; 2003 Apr 24; 41(4):272-3. PubMed ID: 14754531
    [No Abstract] [Full Text] [Related]

  • 36. A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty.
    Bereket A.
    J Clin Res Pediatr Endocrinol; 2017 Dec 30; 9(Suppl 2):33-48. PubMed ID: 29280737
    [Abstract] [Full Text] [Related]

  • 37. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov 30; 13(11):896-9. PubMed ID: 22099200
    [Abstract] [Full Text] [Related]

  • 38. Growth and precocious puberty.
    Chaussain JL, Couprie C, Lacaille F, Simon D, Job JC.
    Acta Paediatr Scand Suppl; 1988 Nov 30; 347():38-43. PubMed ID: 2978196
    [Abstract] [Full Text] [Related]

  • 39. The use of GnRH agonists in precocious puberty.
    Mul D, Hughes IA.
    Eur J Endocrinol; 2008 Dec 30; 159 Suppl 1():S3-8. PubMed ID: 19064674
    [Abstract] [Full Text] [Related]

  • 40. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
    Mul D, Oostdijk W, Waelkens JJ, Drop SL.
    Clin Endocrinol (Oxf); 2005 Aug 30; 63(2):185-90. PubMed ID: 16060912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.